Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart

被引：0
作者：
A. M. Peiró
M. Farré
P. N. Roset
M. Carbó
M. Pujadas
M. Torrens
J. Camí
R. de la Torre
机构：
[1] IMIM-Hospital del Mar Medical Research Institute,Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Programme
[2] Universitat Autònoma de Barcelona (UDIMAS-UAB),CIBER de Fisiopatología de la Obesidad y Nutrición (CB06/03)
[3] Universitat Pompeu Fabra (CEXS-UPF),undefined
[4] Addiction Unit - INAD,undefined
[5] Doctor Aiguader 88,undefined
[6] CIBEROBN,undefined
来源：
Psychopharmacology | 2013年 / 225卷
关键词：
MDMA; Ecstasy; Repeated dose; Humans; Metabolic inhibition; Pharmacologic effects; Pharmacokinetics; CYP2D6;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：883 / 893
页数：10
相关论文
共 50 条
[11]   Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA; ''Ecstasy'') [J].
Cohen, RS ;
Cocores, J .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1997, 21 (04) :727-734
[12]   A review on the mitochondrial toxicity of "ecstasy" (3,4-methylenedioxymethamphetamine, MDMA) [J].
Capela, Joao Paulo ;
Carvalho, Felix Dias .
CURRENT RESEARCH IN TOXICOLOGY, 2022, 3
[13]   The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats [J].
Mechan, AO ;
Esteban, B ;
O'Shea, E ;
Elliott, JM ;
Colado, MI ;
Green, AR .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (01) :170-180
[14]   The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA) [J].
Cole, JC ;
Sumnall, HR .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2003, 27 (03) :199-217
[15]   MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: The neuropsychobiological implications of taking it at dances and raves [J].
Parrott, AC .
NEUROPSYCHOBIOLOGY, 2004, 50 (04) :329-335
[16]   Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat [J].
Upreti, Vijay V. ;
Eddington, Natalie D. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (04) :1593-1605
[17]   Demographic and health characteristics of 3,4-methylenedioxymethamphetamine users (MDMA, ecstasy) [J].
Wieckiewicz, Gniewko ;
Danel, Dariusz ;
Piegza, Magdalena ;
Gorczyca, Piotr ;
Pudlo, Robert .
PSYCHIATRIA POLSKA, 2022, 56 (05) :1109-1130
[18]   (±)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats [J].
Morley, KC ;
McGregor, IS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 408 (01) :41-49
[19]   Post-Mortem (Re)Distribution of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): Human and Animal Data [J].
De Letter, Els A. ;
Stove, Christophe P. ;
Lambert, Willy E. ;
Piette, Michel H. A. .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2010, 11 (05) :453-459
[20]   ASSESSMENT OF THE DISCRIMINATIVE STIMULUS EFFECTS OF THE OPTICAL ISOMERS OF ECSTASY (3,4-METHYLENEDIOXYMETHAMPHETAMINE, MDMA) [J].
BAKER, LE ;
BROADBENT, J ;
MICHAEL, EK ;
MATTHEWS, PK ;
METOSH, CA ;
SAUNDERS, RB ;
WEST, WB ;
APPEL, JB .
BEHAVIOURAL PHARMACOLOGY, 1995, 6 (03) :263-275
12345